drug paper - Lou Raia Paper #2 Prescription drug...

Info iconThis preview shows pages 1–3. Sign up to view the full content.

View Full Document Right Arrow Icon
Lou Raia Paper #2 Prescription drug manufacturers believe they are correct in direct to consumer advertising of their products. They feel that not only do they make safe products, but by communicating with their customers through television, radio, print, and various other methods of marketing, they are providing an additional service to their customers and potential consumers of their products. Critics believe that these drug makers are simply creating customers regardless of whether people actually need the product or not. These critics want the marketing mentioned above to be banned. These opposing opinions obviously clash as the critics find the practices of the drug companies to be unethical. This is a case about rights. Who has them, who does not, and which side should prevail? From a deontological view, I find this to be a fairly simple question to answer. Drug companies are a very important industry in our nation and have played a vital role in improving the quality of our lives for many decades. Their right to advertise and market products is in no way immoral or unethical. If we prevented them from marketing, who would be next and how would we decide? Critics claim that by pushing the medicines via marketing, overdoses occur. Is that possible? Certainly and we have approximately 26,000 fatal overdoses per year (Szabo). We also have over 43,000 fatalities from car accidents each year (Fatal Car Accident). Is anyone screaming to have car commercials pulled off your television? The reason no one makes that argument is cars are basically a safe product when used as they were intended and within the legal speeds assigned by local officials. But from a deontological view, we do not look at the consequences. The critics ONLY look at the consequences. They do not respect or adhere to the
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
principle that businesses, as long as they are not directly harming someone with their products, have every right to inform potential customers of what they are selling. The critics do not take into account the rights of the stakeholders of drug companies.
Background image of page 2
Image of page 3
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 02/19/2012 for the course MGMT 368 taught by Professor Green during the Winter '10 term at Columbia College.

Page1 / 5

drug paper - Lou Raia Paper #2 Prescription drug...

This preview shows document pages 1 - 3. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online